mementor develops and distributes digital medical products in the field of sleep medicine and related areas. Originally founded in 2014 in Switzerland by Dr. Noah Lorenz, Alexander Rötger, Jan Kühni, and Daniel Rotzetter, mementor has had its headquarters in Leipzig since January 2020. mementor's "Apps on Prescription" address the limitations of conventional patient care. The goal is to remove treatment barriers and provide patients access to evidence-based therapeutic methods.

Our team aims to provide effective digital health tools for the treatment of physical or psychological illnesses. We strive to close existing gaps in healthcare and shape the future of digital medicine. High scientific standards, an evidence-based approach, strict data protection requirements, and patient safety are our priorities.

Information and patient safety are priorities at mementor. The company is certified according to DIN EN ISO/IEC 27001 for information security and DIN EN ISO 13485 for quality management, ensuring the production of high-quality medical products. Annual internal and external audits guarantee ongoing quality and safety.

Since August 2, 2022, mementor DE GmbH is part of ResMed in Germany. Together, they aim to leverage expertise to provide more people with effective and accessible alternative therapy options for sleep disorders, closing care gaps. As a leading provider of therapy for sleep-related breathing disorders and respiratory diseases outside hospitals, ResMed expands its portfolio in digital sleep medicine through this acquisition. mementor operates as an independent business unit within ResMed Germany, serving as a foundation for future digital health developments. Founders Dr. Noah Lorenz and Katherina Jekerle lead the management team.